All In Biotech

Drug Trial Radar · NCT05463731

A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Assessment of Safety, Tolerability, and Efficacy Measured by Amyloid Reduction of LY3372993 in Early Symptomatic Alzheimer's Disease

Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,667 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,667

Actual

Start

Aug 1, 2022

Primary completion

Apr 24, 2024

Study completion May 12, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's disease (AD).

Conditions

  • Alzheimer's Disease

Interventions

  • Remternetug (IV)Drug

    Administered IV

  • Remternetug (SC)Drug

    Administered SC

  • PlaceboDrug

    Administered IV or SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Reach Amyloid Plaque Clearance on Amyloid PET Scan for Remternetug versus PlaceboTime frame: Week 52

Locations

76 sites in 2 countries. Site status is shown where the registry gives one.

  • MD First Research - Chandler

    Chandler, Arizona

  • Hope Clinical Research, Inc.

    Canoga Park, California

  • North County Neurology Associates

    Carlsbad, California

  • Wr- Pri, Llc

    Encino, California

  • Neuro-Pain Medical Center

    Fresno, California

  • Irvine Clinical Research

    Irvine, California

  • Kaizen Brain Center

    La Jolla, California

  • Anderson Clinical Research

    Redlands, California

  • Mountain Neurological Research Center

    Basalt, Colorado

  • Alpine Clinical Research Center

    Boulder, Colorado

  • Colorado Springs Neurological Associates

    Colorado Springs, Colorado

  • Institute for Neurodegenerative Disorders

    New Haven, Connecticut

  • Ki Health Partners, LLc, dba New England Institute for Clinical Research

    Stamford, Connecticut

  • JEM Research Institute

    Atlantis, Florida

  • VIN-Julie Schwartzbard

    Aventura, Florida

  • Brain Matters Research

    Delray Beach, Florida

  • Neuropsychiatric Research Center of Southwest Florida

    Fort Myers, Florida

  • Finlay Medical Research

    Greenacres City, Florida

  • Encore Research Group- Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • ClinCloud - Maitland

    Maitland, Florida

  • K2 Medical Research

    Maitland, Florida

  • ClinCloud - Viera

    Melbourne, Florida

  • Merritt Island Medical Research, LLC

    Merritt Island, Florida

  • VIN-Andrew Lerman

    Miami, Florida

  • Optimus U Corporation

    Miami, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Charter Research - Winter Park

    Orlando, Florida

  • Emerald Coast Neurology - Airport Boulevard

    Pensacola, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Alzheimer's Research and Treatment Center

    Stuart, Florida

  • Brain Matters Research

    Stuart, Florida

  • Tallahassee Neurological Clinic

    Tallahassee, Florida

  • Charter Research - Lady Lake

    The Villages, Florida

  • Alzheimer's Research and Treatment Center

    Wellington, Florida

  • Palm Beach Neurology

    West Palm Beach, Florida

  • Conquest Research

    Winter Park, Florida

  • Columbus Memory Center, PC

    Columbus, Georgia

  • iResearch Atlanta

    Decatur, Georgia

  • Great Lakes Clinical Trials - Andersonville

    Chicago, Illinois

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.